Prestige Wealth Management Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Prestige Wealth Management Group's CORT Position: Q3 2026 in Review
Prestige Wealth Management Group held its Corcept Therapeutics (CORT) position steady in Q3 2026 at 34 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #616.
Prestige Wealth Management Group first reported a position in CORT in Q1 2026 and has held it in 3 quarters since. 501 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Prestige Wealth Management Group held 34 shares of Corcept Therapeutics worth $3.92K as of Q3 2026.
- Prestige Wealth Management Group left its Corcept Therapeutics share count unchanged in Q3 2026.
- Corcept Therapeutics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q3 2026, its #616 holding.
- Prestige Wealth Management Group first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 501 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Prestige Wealth Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.